Skip to main content

Benign Prostatic Hyperplasia Risk Increased for Patients With Chronic Prostatitis

Medically reviewed by Carmen Pope, BPharm. Last updated on April 3, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, April 3, 2024 -- Patients with chronic prostatitis (CP) have an increased risk for developing benign prostatic hyperplasia (BPH), according to a study published online March 9 in the World Journal of Urology.

Tsung-Yen Lin, from the National Cheng Kung University Hospital Dou-Liou Branch in Taiwan, and colleagues analyzed the medical claims of Taiwan's National Health Insurance Program to examine the association between CP and subsequent development of BPH. A total of 3,571 patients aged 20 years and older with CP diagnosed by certified urologists from 2010 to 2017 were enrolled. Age-matched controls were randomly selected from all non-CP individuals with a CP-to-non-CP ratio of 1:4.

The researchers found that 287 and 258 BPH events were noted for the CP and non-CP groups, respectively, during a maximum follow-up of eight years (8.03 and 0.43 percent, respectively), representing a covariate-adjusted hazard ratio for CP of 4.30. Higher adjusted hazard ratios were seen for younger patients, especially those aged 20 to 39 years (adjusted hazard ratio, 11.45).

"The Taiwan national health database indicated that CP patients had a significantly higher risk of developing BPH later than non-CP patients. Interestingly, the younger the CP is diagnosed (under 40), the greater the risk," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

Prostatic Artery Embolization Offers Lasting Benefit for BPH

THURSDAY, Oct. 3, 2024 -- For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) is safe and effective over 24 months of follow-up, according to a...

Surgical Techniques Compared for ThuLEP for Benign Prostatic Hyperplasia

TUESDAY, Aug. 6, 2024 -- For patients undergoing Thulium laser enucleation of the prostate (ThuLEP) for benign prostatic hyperplasia (BPH), there are no significant differences in...

Aquablation, HoLEP Provide Unique Benefits for Men With Benign Prostate Hyperplasia

TUESDAY, June 4, 2024 -- For men with benign prostate hyperplasia, aquablation provides temporary benefits for ejaculation and continence at three months, while holmium laser...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.